Registration
CAPITOL COUNSEL LLC for AMICUS THERAPEUTICS, INC.
Firm
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislative and regulatory issues affecting SMID rare disease biotech companies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MARTIN New | Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton. |
| KAREN STONE New | Legislative Director, Rep. Dina Titus; Legislative Correspondent/Staff Assistant, Rep. Steve Israel; Senior Legislative Assistant, Rep. Steve Israel. |
Medicare/Medicaid MMM
Legislative and regulatory issues affecting SMID rare disease biotech companies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MARTIN New | Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton. |
| KAREN STONE New | Legislative Director, Rep. Dina Titus; Legislative Correspondent/Staff Assistant, Rep. Steve Israel; Senior Legislative Assistant, Rep. Steve Israel. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.